FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * LOPEZ GEORGE A   2. Issuer Name and Ticker or Trading Symbol ICU MEDICAL INC/DE [ICUI] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner __X__ Officer (give title below) __X__ Other (specify below) Chairman / Chairman (Last) (First) (Middle) 951 CALLE AMANECER 3. Date of Earliest Transaction (Month/Day/Year) 10/13/2006 (Street) SAN CLEMENTE, CA 92673 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 10/13/2006   X   27,444 A $ 5.5417 41,466 D   Common Stock 10/13/2006 10/13/2006 S   1,444 D $ 48 40,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0008 39,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0009 38,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0033 37,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.007 36,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0248 35,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0301 34,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0351 33,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0365 32,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0496 31,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.052 30,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0571 29,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0658 28,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0715 27,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0794 26,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0881 25,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.0954 24,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.1007 23,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.1038 22,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.1219 21,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.1256 20,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.1264 19,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.1321 18,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.1468 17,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.1505 16,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.1709 15,022 D   Common Stock 10/13/2006 10/13/2006 S   1,000 D $ 48.1902 14,022 D   Common Stock               1,186,843 I by Partnership (1) Common Stock               23,223 I by Trust (2)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Non-Qualified Stock Option (right to buy)

$ 5.5417

10/13/2006

X

27,444

01/30/1999

01/31/2008

Common Stock

27,444

(3)

3,845

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
LOPEZ GEORGE A 951 CALLE AMANECER SAN CLEMENTE, CA 92673	X		Chairman	Chairman

Signatures

By: Lynn DeMartini For: George A. Lopez, M.D.		10/16/2006
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Excludes 22,959 shares held by Diana K. Lopez, M.D. Dr. Lopez disclaims any beneficial interest in the shares held by his wife.
(2)	Common Stock owned by Lopez Family Trust. Dr. Lopez is trustee and beneficiary of the Family Trust. Except to the extent of his peciuniary interests as beneficiary of the Family Trust, Dr. Lopez disclaims any beneficial ownership of the shares owned by the Family Trust.
(3)	Transaction is the exercise of a derivative security; see Column 2.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.